Thursday - December 04, 2025

socialmed.ai Announces AI Search Visibility: The New Standard for How Businesses Get Found Inside AI Models

Edmonton, Canada – socialmed.ai | Strategic Partners today announced the launch of AI Search Visibility, a new methodology redefining how companies are discovered, recommended, and ranked inside AI systems such as ChatGPT, Perplexity, Claude, and Gemini. As global search behaviour continues … Continue reading

Severe Asthma Clinical Pipeline 2025: A Comprehensive Review of 50+ Emerging Therapies from 40+ Innovators, says DelveInsight

Severe Asthma Clinical Trial Leading companies active in the Severe Asthma therapeutic landscape include Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical … Continue reading

Helicobacter pylori Infection market size in the 7MM was approximately USD 2,672.5 million in 2022 and is projected to increase by 2034 | DelveInsight

Helicobacter pylori Infection market Leading companies active in the Helicobacter pylori (H. pylori) infection treatment landscape include Servatus Biopharmaceuticals, Cinclus Pharma Holding AB, Crestone, EpiVax, Iguana Biotechnology, ImevaX GmbH, ImmunoBiology, Luoxin Pharmaceuticals, Nexbiome Therapeutics, Recce Pharmaceuticals, RedHill Biopharma Ltd, SCG … Continue reading

Global Hypertension Patient Journey Study Uncovers Critical Insights to Strengthen Commercialization Strategies | DelveInsight

Hypertension Patient Journey Study Enhancing Hypertension Patient Journey Understanding Across Key Global Markets Global Hypertension Patient Journey Study Uncovers Critical Insights to Strengthen Commercialization Strategies | DelveInsight Enhancing Hypertension Patient Journey Understanding Across Key Global Markets A leading life sciences … Continue reading